⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3810403 | 1.00 | — | — | |
| SCHEMBL627879 | 1.00 | — | — | |
| SCHEMBL1668773 | 0.97 | EPHX1 (0.46) | — | |
| SCHEMBL17269701 | 0.83 | EPHX1 (0.36) | — | |
| SCHEMBL16482373 | 0.83 | EPHX1 (0.36) | — | |
| SCHEMBL15627990 | 0.79 | EPHX1 (0.37) | — | |
| SCHEMBL27209741 | 0.79 | — | — | |
| SCHEMBL15105747 | 0.77 | EPHX1 (0.36) | — | |
| SCHEMBL15105745 | 0.77 | EPHX1 (0.36) | — | |
| SCHEMBL15105748 | 0.77 | EPHX1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0609025-B1 | Process for producing optically active epoxy alcohol derivatives | ARCO CHEM TECH (US) | 1996-04-17 | — | — | EP | claimed |
| EP-0609025-A1 | Process for producing optically active epoxy alcohol derivatives | ARCO Chemical Technology, L.P. (US) | 1994-08-03 | — | — | EP | claimed |
| US-5252759-A | Reacting with organic sulfonyl halide to produce organic sulfonate | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1993-10-12 | — | — | US | claimed |
| EP-4644396-A1 | TOLL-LIKE RECEPTOR INHIBITOR, AND PREPARATION THEREFOR AND APPLICATION THEREOF | Visionpharma (Nantong) Co., Ltd (CN) | 2025-11-05 | — | — | EP | disclosed |
| US-20250326773-A1 | MRGPRX2 ANTAGONISTS, PHARMACEUTICAL COMPOSITION INCLUDING MRGPRX2 ANTAGONIST, AND METHOD OF TREATING MRGPRX2-MEDIATED DISEASE OR DISORDER | KYORIN SEIYAKU KK (JP) | 2025-10-23 | — | — | US | disclosed |
| US-20250326772-A1 | MRGPRX2 ANTAGONISTS, PHARMACEUTICAL COMPOSITION INCLUDING MRGPRX2 ANTAGONIST, AND METHOD OF TREATING MRGPRX2-MEDIATED DISEASE OR DISORDER | KYORIN SEIYAKU KK (JP) | 2025-10-23 | — | — | US | disclosed |
| US-20240190837-A1 | CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS | SYCHRONICITY PHARMA INC (US) | 2024-06-13 | — | — | US | disclosed |
| US-20230365558-A1 | TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF | MEDSHINE DISCOVERY INC. (CN) | 2023-11-16 | — | — | US | disclosed |
| US-20220411399-A1 | CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS | SYCHRONICITY PHARMA INC (US) | 2022-12-29 | — | — | US | disclosed |
| US-20220411399-A1 | CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS | SYCHRONICITY PHARMA INC (US) | 2022-12-29 | — | — | US | disclosed |
| CN-110003172-B | Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators | 同步制药公司 | 2022-04-01 | — | — | CN | disclosed |
| EP-0618914-A1 | OXIRANYL METHYL ETHERS EXHIBITING CHIRALITY, AND THEIR USE AS DOPANTS IN LIQUID-CRYSTAL MIXTURES | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-10-12 | — | — | EP | disclosed |
| US-5354872-A | Process for preparation of calcitriol lactone and related intermediates | ALCON LABORATORIES, INC. (US) | 1994-10-11 | — | — | US | disclosed |
| US-5332807-A | Process of producing 8A- and 9A-azalide antibiotics | MERCK & CO., INC. (US) | 1994-07-26 | — | — | US | disclosed |
| WO-1994015617-A1 | 8A-AZA AND 9A-AZA MACROLIDE ANTIBIOTICS, AND A PROCESS FOR PRODUCING SAME AND METHODS OF USE | MERCK & CO., INC. (US) | 1994-07-21 | — | — | WO | disclosed |
| EP-0599203-A1 | N,N-disubstituted arylcycloacrylamines, their salts, medicines containing these compounds and their use as well as processes for their preparation | Dr. Karl Thomae GmbH (DE) | 1994-06-01 | — | — | EP | disclosed |
| US-5283346-A | Chemical intermediate for vitamin e | HOFFMANN-LA ROCHE INC. (US) | 1994-02-01 | — | — | US | disclosed |
| US-5232852-A | Enzymatic hydrolysis utilizing a lipase | HOFFMANN-LA ROCHE INC. (US) | 1993-08-03 | — | — | US | disclosed |
| WO-1993013093-A1 | OXIRANYL METHYL ETHERS EXHIBITING CHIRALITY, AND THEIR USE AS DOPANTS IN LIQUID-CRYSTAL MIXTURES | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-07-08 | — | — | WO | disclosed |
| EP-0388778-A2 | Preparation of dioxolane derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1990-09-26 | — | — | EP | disclosed |